NGS-Based Mutation Profiling and PD-L1 Expression in NSCLC Patients: A Single-Centre Prospective Analysis
{{output}}
Objective: Non-small cell lung cancer (NSCLC) is a molecularly heterogeneous disease in which both actionable mutations and PD-L1 expression influence therapeutic decisions. This study aimed to evaluate the molecular profile of N... ...
